Related Experiment Video
Updated: May 30, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Ricin vaccine development.
Joan E Smallshaw1, Ellen S Vitetta
1The Cancer Immunobiology Center, Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, USA.
Current Topics in Microbiology and Immunology
|August 2, 2011
Summary
Developing vaccines against ricin, a toxic plant-derived substance, is crucial for bioterrorism defense. Two recombinant vaccines and neutralizing antibodies are leading candidates for protection.
Area of Science:
- Toxicology
- Immunology
- Biodefense
Background:
- Ricin is a highly toxic plant-derived toxin with potential for espionage and bioterrorism.
- Its prevalence, ease of use, and stability increase the threat.
- Developing effective countermeasures is a priority for public health and security.
Purpose of the Study:
- To review current vaccine and antidote development against ricin.
- To discuss leading vaccine candidates and passive antibody protection strategies.
- To contextualize these developments within ricin's toxicity and structure.
Main Methods:
- Review of existing research on ricin vaccines and antibodies.
- Discussion of recombinant vaccine candidates.
- Analysis of monoclonal neutralizing antibodies for passive immunization.
Main Results:
- Two recombinant vaccines are identified as leading candidates for national stockpiles.
- Monoclonal neutralizing antibodies are under development for passive post-exposure protection.
- Ongoing research focuses on safe and effective human protection strategies.
Conclusions:
- Vaccine and antibody development are critical for mitigating ricin's bioterrorism threat.
- Recombinant vaccines and neutralizing antibodies show promise for protection.
- Continued research is essential to ensure preparedness against ricin exposure.
